Skip to Content
Merck
CN
  • Case report: Non-invasive management of Madura foot with oral posaconazole and ciprofloxacin.

Case report: Non-invasive management of Madura foot with oral posaconazole and ciprofloxacin.

The American journal of tropical medicine and hygiene (2014-10-29)
Amit M Sharma, Namita Sharma, Amritpal Nat, Meghan Rane, Timothy P Endy
PMID25349373
ABSTRACT

Madura foot is a chronic infection caused by fungus and/or bacteria. Traditionally, treatment has been surgical debridement or amputation. Non-invasive management with long-term antimicrobials alone has been reported as successful. We report a case of Madura foot in a Somali refugee successfully managed with oral posaconazole and ciprofloxacin.

MATERIALS
Product Number
Brand
Product Description
PHR1044
Supelco
Ciprofloxacin HCl, Pharmaceutical Secondary Standard; Certified Reference Material
33434
Supelco
Ciprofloxacin, VETRANAL®, analytical standard
PHR1167
Supelco
Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
17850
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
1134335
USP
Ciprofloxacin hydrochloride, United States Pharmacopeia (USP) Reference Standard
C2190000
Ciprofloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Y0000198
Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard
Y0000199
Ciprofloxacin hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard